Everybody but an economist knows without asking why money shouldn't buy some things.
Arthur Okun,
Equality and Efficiency: The Big Tradeoff1
Okun A. Equality and Efficiency: The Big Tradeoff. Washington, D.C.: The Brookings Institution, 1975, 13.
Money plays a powerful role in modern medicine, both in terms of how health services are organized and delivered and increasingly in how physicians understand themselves and their work. The phrase “the hegemony of money” is intended to capture that power.
“Hegemony” is derived from the Greek term for leadership or dominance. Its original context of use was political, referring, for example, to the dominance of one Greek city-state over another or one nation over others. Contemporary usage, following Antonio Gramsci, extends far beyond supremacy in international relations to cultural dominance of one class over another—embodied, for example, in the way institutions such as political parties, religious organizations, and the media are successful in projecting their view as accepted by and even natural to those who are subordinated by it.2
For an excellent edition of Gramsci's work, see Hoare Q, Smith GN, eds. Selections from the Prison Notebooks. London: Lawrence and Wishart; 1971. For an exposition of the importance of Gramsci's thought for culture and society see Crehan K. Gramsci, Culture and Anthropology. London: Pluto Press; 2002. Crehan claims that “hegemony” should be defined as the (often implicit) consent given to the powerful organizing forces of society, as opposed to the coercive power exercised by the police power of the state. See 102–4ff.
This essay is an exploration of the cultural meaning attached to money and not simply to its pervasive presence in American medicine. The growing power of money in medicine is well recognized and is perhaps best expressed as the increasing commercialization of practice. Two recent and well-written books, one by Marcia Angell3
Angell M. The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House; 2004.
Kassirer J. On The Take: How Medicine's Complicity with Big Business Can Endanger Your Health. New York: Oxford University Press; 2005.
First I want to paint the larger picture of commercialism in contemporary American culture, because without this context it is difficult to see how medicine could have become so besieged and seduced by commercial forces. Next I will focus more briefly on changes in medical practice per se, rehearsing what is for many readers some familiar ground in the recent transition from a service-based professional activity to a managerially driven production model of medicine. One of my chief concerns here is the toll the commercialization of practice organization takes on the sensibility of physicians. Finally, I will respond to the question implicitly posed in the subtitle of this essay: Is there hope for medicine retaining its professionalism in a commercial environment? I do believe that professionalism in medicine is still possible, but I have no illusions that it will be easy. My view is that medicine is not simply a little off course, but profoundly disoriented. Loosening the power of commercial hegemony and sustaining a truly professional role for doctors will require far more changes than either physicians or the general public typically imagine. Real change will require not just tinkering with financial incentives or properly regulating managed care organizations (MCOs). What will be required is a basic reorientation of the aims and purposes of medical work and healthcare institutions.
Everything for Sale
Immanuel Kant said that everything has either a price, or it possesses dignity.5
Kant I. Foundations of the Metaphysics of Morals. Beck LW, trans. New York: Macmillan; 1985:53ff.
Tucker AM. Ethics and the professional team physician. Clinical Sports Medicine 2004;23:227–41.
At the individual level, status seems to be for sale. Traditionally, socioeconomic status depended on three variables—occupation, education, and income. The hegemony of money means that raw purchasing power has come to displace the other two. In a real and not just symbolic sense, it seems possible now to market oneself into a different social stratum.
Markets, to be sure, have much to recommend them. They supply consumers with broad choices and cater to aspects of freedom, liberty, and personal choice that are major parts of the American sense of fulfillment and well-being. Markets promote innovations and they often—though not always—reward efficiency. Markets often produce higher quality, or at least they promote, when consumers are savvy, transparency in quality and relate it directly to price. So very few would argue that, with regard to shirts, shoes, plasma TVs, and a large range of others goods and services, markets work wonderfully. For many goods and services, they do, in fact, promote the kind of benefits Adam Smith had in mind when he discussed the magical way that the pursuit of self-interest leads to general prosperity.7
See Smith's An Inquiry into the Nature and Causes of the Wealth of Nations, Vol. 1. Campbell RH, Skinner AS, eds. Oxford: Clarendon Press; 1976:26–7, 456ff. The “invisible hand,” which affects social benefits from pursuit of self-interest, is also a motif of Smith's earlier writings. See The Theory of Moral Sentiments, Raphael DD, Macfie AL, eds. Indianapolis: Liberty Classics; 1982:184–5.
For an excellent historical contextualization of Smith's work and its applicability to modern societies, see Mueller JZ. Adam Smith in His Time and Ours: Designing the Decent Society. New York: The Free Press; 1993.
The problem lies in the idea, lately resurgent, that markets can solve most or all our problems, that commercialization is a universally applicable model for most kinds of human exchange. When everything is for sale, as Kant noted, essential aspects of personal, social, and professional life are stripped of their dignity, and the infrastructure on which markets themselves depend for their well-functioning is often threatened. It makes little sense to strive for increases in the material standard of living if by so doing the air and water are left increasingly polluted. As Robert Kuttner notes, the hegemony of money implicit in rampant commercialism is finally detrimental to the social fabric, diminishing the nonmarket values and norms on which many things—including well-functioning markets—depend.9
Kuttner R. Everything for Sale: The Virtues and Limits of Markets. New York: Alfred A. Knopf; 1997:39–67.
But of course it would be simplistic to lay the entire problem of the hegemony of money at the feet of markets. There is also, ironically, a sense in which the superordinate position of money in our culture is a result of democratic and egalitarian trends in society, that is, a result of the breakdown of inherited status and the emergence of wealth as a mark of moral worth.
Money and Moral Worth in a Meritocracy
The transformation in Western culture that gave money such enormous muscle in our self-definition and social worth is outlined in Alain de Botton's Status Anxiety.10
de Botton A. Status Anxiety. New York: Pantheon Books; 2004.
See note 10, de Botton 2004:59.
Botton observes that this began to change definitively in the mid-18th century, as the hereditary principle began to be questioned. And as meritocracy increasingly replaced aristocracy, “faith in an increasingly reliable connection between merit and worldly success in turn endowed money with a new moral quality.”12
See note 10, de Botton 2004:65.
Weber M. The Protestant Ethic and the Spirit of Capitalism, Parsons T, trans. New York: Charles Scribner's Sons; 1958. This was first published as a two-part article in 1904–1905.
Of course, within the ideology—if not the fact—of a meritocracy, it is only a short step from the positive sense of personal validation of one's moral worth through possession of money to the negative correlate: that the poor are sinful or lacking in moral character and owe their poverty to precisely this cause. Botton concludes: “To the injury of poverty, a meritocratic system now added the insult of shame.”14
See note 10, de Botton 2004, at p. 71.
I cite Botton because I think he shows clearly how money has a way of boring into our deep, moral sense of self, our soul. Rather than being an external possession that we need to make our lives work, or work smoothly or comfortably, money now tends to say who we are. It is a major indicator of our moral worth, our social and self-understanding. While American culture is officially and rhetorically egalitarian it is unofficially and concretely an aristocracy of money. And while just having money is important, it is also a part of its hegemonic power that we use money to express our identities. We judge ourselves and others by the things that money buys: apparel that sets us apart; houses and cars that purr with their opulence and grandeur; wines, art, and travel that convey our exquisitely refined tastes. We judge others and encourage others to judge us by these measures. Novelist and social critic John Berger has put it succinctly in terms of how consumption has replaced political participation as a mode of self-affirmation. Rather than vote, Berger says, we shop.15
Berger J. Ways of Seeing. London: Penguin; 1972:149.
In this regard, physicians are no different than other professions and occupations in being tempted to define themselves inordinately through money, and arguably they are even more vulnerable to this self-understanding. Making oneself occupationally ready for medicine requires great stretches of time, the sacrifice of a portion of one's youth, and often incurs considerable indebtedness. So a powerful yearning for high compensation to reflect one's social standing is precisely what we should expect from physicians. Botton's analysis simply adds the dimensions of moral worth to this thirst. And to these factors must be added another critical factor—the commercialization of medical practice over the past 30 years, to which I now turn.
The Commercialization of Medical
Practice16 Material for this section was
adapted from Churchill LR. The United States health care system under
managed care: How the commodification of health care distorts ethics and
threatens equity. Health Care Analysis
1999;7(4):393–411.
Material for this section was adapted from Churchill LR. The United States health care system under managed care: How the commodification of health care distorts ethics and threatens equity. Health Care Analysis 1999;7(4):393–411.
Market forces have always been a force in medicine, but it is only recently that they have come to dominate. Although physicians have consistently sought to portray themselves as purveyors of a social service, until recently in the United States they have functioned as small businessmen. For the greater part of the 20th century American medicine was a cottage industry with a professional service ethos, populated by solo or group practices, run on fee-for-service, indemnity insurance, or out-of-pocket patient financing, providing adequate to good returns for most generalists and handsome pecuniary rewards for specialists. Those who received care were largely those who could pay, either though insurance or out of pocket, whereas the uninsured were the sporadic recipients of charity. So the conduct of medical practice as a business, and the use of market forces as the chief mechanism for the distribution of medical goods and services, is nothing new in the United States.
What is new is the pervasive presence of large corporations as owners and providers of health services. Although there were some healthcare corporations in the past, they were typically businesses owned by medical groups or nonprofit organizations that were governed by boards of local citizens and were community oriented. Although not always altruistic in their aims, these organizations were often responsive to local needs. The new healthcare corporation has a Wall Street orientation and is responsive to markets and mergers. The new corporate providers are also far more skilled than the cottage industry entrepreneurs at advertising and selling their services, cutting costs, and shaping the way their customers think not only about the services they offer but about the economic arrangements that undergird their profitability. The healthcare insurance industry's derailing of the Clinton healthcare reforms in 1994 is vivid testimony to their power.
The muscle of the new corporate health entrepreneurs can be documented by looking at the portion of healthcare services they now control, but my interest here is less in the size of their market share and more in the subtle but pervasive ways we have all been encouraged to talk and think about healthcare as a marketable product. For example, physicians are now “providers,” and patients have become “consumers.” The logic of these terminology changes is reinforced by the methods managed care organizations (MCOs) use to assure its members that quality is being maintained or enhanced—through “consumer satisfaction surveys.” The idea that consumer satisfaction is a good measure of quality means that patients now have the role of customers, who, to be effective in this exchange, must be knowledgeable and shrewd in comparisons of price and quality. Health services are now “commodities,” in which the cardinal defect is the absence of choice. The absence of choice prohibits the chief means of consumer assurances of value, namely, comparison shopping. In brief, going to see a doctor is increasingly portrayed as purchasing a product or claiming a service—largely prepaid if one is insured—rather than seeking help from a trusted professional. Of course not all the language changes I note are unambiguous changes for the worse. For example greater patient choice as an expression of personal autonomy can be quite important in healthcare. My criticism is not directed at choice per se, but at the commercialization of choice, the idea that choosing in medical care should be conceived on a commercial paradigm and as a market exercise, rather than as a way of individualizing care in a patient-centered paradigm.
Within the logic of the market, the goal of commercializing health services is to capture a market niche, to enlarge it, and to maximize profits. This, too, is reflected in changes in the idioms that describe the activity. Services to patients by physicians are registered in accountants' ledgers as “medical losses,” precisely because these services reduce the fraction of income that can be counted as profit. Advertising is undertaken to attract and sustain the loyalty of carefully selected, low-risk groups, known as “revenue bodies,” to whom the cheaper premiums are offered. To sustain profitability, corporations employ strategies of “demarketing,” namely, concerted efforts to drive away unprofitable patients and deemphasize unprofitable services. MCOs routinely purchase or develop physicians' profiles to identify physicians who are noncompliant with practice guidelines, provide excessive services, or otherwise incur cost overruns, the objective being, of course, to demarket them as well. Most physicians currently function under a variety of incentive systems designed to reduce utilization, and thus costs, in keeping with the aims of corporate profitability. If efficiency targets are not met, whatever portion of physicians' incomes that were “at risk” is lost. Thus clinical choices about how much time to spend with a patient or what services to provide or recommend have substantial implications for physicians' income. Just how direct and severe these implications are depends on the model being used, and they range from those that simply produce a prudent cost-consciousness to those that are morally perverse because they create a conflict of interest within the physician.
The impact of corporate commercialization on physicians would be hard to overestimate. The literature of the past 20 years has been filled with carping, complaints, and other signs of demoralization. The application of industrial, assembly-line management techniques to medical care has done perhaps more than anything else to reduce the self-esteem of physicians. Seeing more patients for shorter periods of time to meet a managerial quota has led, predictably, to less satisfying relationships for both physicians and patients.
In sum, it would be very strange if the hegemony of money had not invaded the medical sensibility. Physicians are subject to the same pressures as all Americans, increasingly measuring in dollars how they rank as good professionals, good family providers, good citizens, and generally as good persons. In American society, these indices of merit and honor are all thought to be related, directly or indirectly, to the monetary resources one can muster. But physicians have also had a significant portion of their professional independence and autonomy stripped away by corporate managers, and they have been systematically encouraged to think of their stewardship of money—rather than, or in addition to, their stewardship of patients—as the right way to measure whether they are “good” doctors. In this transition, money can become the substitute for the lost sense of professional self-worth. In the past this sense of worth could be derived from developing therapeutic relationships and a general altruism of purpose. The industrial–managerial model of care makes these sources of reward less available.
Money: A Cruel God for Health Professionals
Several years ago I was talking to a surgeon who was my host for a visiting lecture at his institution. Arriving in the early afternoon for an after-dinner talk, he took me to the construction site of his new home and we walked together through the emerging shell of beams and girders. It was to be a grand house, roughly 15,000 square feet, with rooms for every possible activity, multiple garages, and more amenities than I had ever seen in a private residence—and all for two people. Clearly it represented the fulfillment of his and his spouse's aspirations. His comment to me, half in apology, was “It gives me a reason to keep working.”
I tell this story not because I begrudge physicians, or anyone for that matter, wealth or fulfillment of their aspirations. Rather what was striking to me was that “conspicuous consumption”17
The phrase is Thorstein Veblen's, coined in 1899 in his The Theory of the Leisure Class. New York: Dover; 1994.
In the end, money is a cruel god, not worthy of devotion. And this is perhaps the clearest way of saying what is troubling about this elusive but all-important interior and motivational dimension of the hegemony of money in medicine: the cruelty lies in the way money overpowers all other values and thereby uproots physicians of the deep rewards of recognizing themselves as part of a healing process. Money (and the considerable list of things it can buy) becomes the chief standard against which doctors judge themselves and seek to be judged. But for professionals, the only god worthy of solemn devotion is signified in the etymology of “profession,” namely, an avowal of service beyond self.18
The Oxford English Dictionary provides some interesting etymological senses of “profession” that are helpful here.
In describing how commercial managed care has undermined public trust in physicians, William Sullivan has asserted: “It is hard to see how medicine can resolve its crisis of legitimacy without simultaneously seeking to redefine its identity around a public mission.”19
Sullivan W. What is left of professionalism after managed care? The Hastings Center Report 1999;29:7–13. If further evidence if needed for the demise of the public confidence in physicians as professionals, a recent survey by the American College of Physicians indicated that in terms of being respected and admired, physicians now rate fifth, behind druggists and grade-school teachers, and that 9 out of 10 physician leaders surveyed (from a pool of over 1400), were either “very concerned” or “moderately concerned” about unethical business practices tainting healthcare. See Romano M. Perception is everything. Modern Healthcare 2005;35:6–7,16.
